Cyrus J. Lawrence’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-80
Closed -$4K 232
2022
Q2
$4K Hold
80
﹤0.01% 251
2022
Q1
$6K Buy
+80
New +$6K ﹤0.01% 250